Robotic Surgery in India: A Necessary Advancement or a Luxury Tool?
Robotic-assisted surgery (RAS) has emerged as one of the most significant technological innovations in modern healthcare. In India, a country grappling with a massive disease burden, an aging population, and rising cases of cancer and lifestyle-related disorders, the question is no longer whether robotic surgery has a place, but how effectively and equitably it can be integrated into the healthcare system.
Why India Needs Robotic Surgery
Robotic systems, such as the da Vinci platform and indigenous alternatives like SSI Mantra and Meril’s Misso, offer distinct clinical advantages that address many of India’s healthcare challenges. These systems provide surgeons with high-definition 3D vision, enhanced dexterity, tremor filtration, and greater precision than traditional laparoscopic or open surgery. The result is reduced blood loss, lower infection rates, minimal scarring, shorter hospital stays, and faster patient recovery.
These benefits are particularly valuable in high-volume specialties including urology, gynecology, oncology, orthopedics, and select cardiac procedures. With cancer incidence and complex joint replacements on the rise, robotic surgery enables better outcomes in technically demanding operations. Additionally, it reduces surgeon fatigue during lengthy procedures and supports medical tourism, which brings valuable revenue to the sector.
India’s public sector has also begun embracing the technology. Institutions like AIIMS Delhi have crossed significant milestones in robotic case volumes, while telesurgery initiatives aim to extend expertise to remote and underserved regions. Indigenous development of robotic platforms aligns with national goals of technological self-reliance and cost reduction.
Rapid Growth in Adoption
The adoption curve has been steep. From a modest base of around 66 robotic centers in 2019, India now hosts over 170 da Vinci systems along with hundreds of other platforms, including nearly 290 orthopedic robots. The country has trained between 850 and 1,500 surgeons, and annual robotic procedures are estimated between 50,000 and 60,000. The market, valued at approximately $851 million in 2023, is projected to reach $4 billion by 2031, growing at a double-digit CAGR.
This expansion reflects both clinical demand and growing confidence among hospitals and surgeons.
Persistent Challenges and Limitations
Despite its promise, robotic surgery is not without significant hurdles. The biggest barrier remains cost. Robotic systems require multi-million-dollar investments, expensive consumables, and regular maintenance. As a result, procedures often cost ₹1.5–4 lakh more than conventional methods, making them accessible primarily to affluent patients and those with robust insurance coverage.
Infrastructure and training gaps further limit impact. Most robotic centers are concentrated in metropolitan cities, leaving Tier-2, Tier-3, and rural areas largely untouched. While the number of trained surgeons is increasing, it remains insufficient relative to the country’s vast population and surgical needs. Underutilization in some facilities also raises questions about return on investment.
Importantly, robotic surgery is not superior in every scenario. In emergencies, certain highly complex cases, or situations requiring strong tactile feedback, traditional open or laparoscopic techniques may still be preferable. Mechanical reliability, though high, is not absolute, and surgeons must complete a steep learning curve.
The Road Ahead
Robotic surgery is clearly needed in India to elevate surgical precision, improve patient outcomes, and modernize healthcare delivery in select domains. It is not, however, a universal solution or an immediate replacement for established methods. Traditional and laparoscopic surgery will continue to serve the majority of patients, especially in resource-constrained settings.
The path forward lies in strategic scaling. Lowering costs through indigenous manufacturing, expanding training programs, increasing penetration in government hospitals, and integrating robotic procedures into insurance frameworks are essential steps. A hybrid approach—using robotics where it delivers the greatest clinical and economic value—will maximize its benefit.
In conclusion, robotic surgery represents a valuable and increasingly vital tool for India’s healthcare evolution. With thoughtful policy support, focused investment, and continued innovation, it has the potential to move from an elite offering to a broader contributor to surgical excellence across the country. The coming decade will determine whether India harnesses this technology to bridge quality gaps or allows it to remain a symbol of urban-private healthcare disparity.
About The Author
